EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancer

Wing-Lok Chan iD, Ho-Kwan Bryan Yun, Emina Edith Cheung, Michelle Liu, Li-Yu Hou, Ka-On Lam, Ian Yu-Hong Wong, Wan-Hang Keith Chiu, Simon Law, Dora Kwong

The Oncologist · 03.10.2024 · 29 (10) · e1272-e1279

DOI: 10.1093/oncolo/oyae123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, online erschienen am 17.06.2024. Verfasst von Wing-Lok Chan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong. Hauptthemen laut MEDLINE: Sarcopenia, Stomach Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia or skeletal muscle depletion is a poor prognostic factor for gastric cancer (GC). However, existing cutoff values of skeletal muscle index (SMI) for defining sarcopenia have been found to have limitations when clinically applied. This study aimed to determine the optimal cutoff for SMI to predict severe toxicities of chemotherapy and overall survival (OS) in patients with advanced GC.

Methods

Patients with metastatic gastric adenocarcinoma who received first-line palliative chemotherapy between January 2014 and December 2021 at Queen Mary Hospital, Hong Kong, were included in this study. The SMI was determined via a pre-chemotherapy computed tomography scan. Optimal cutoff points of SMI were identified by recursive partitioning analysis. Univariate and multivariate analyses evaluating risk factors of severe chemotherapy toxicities and OS were also performed.

Results

A total of 158 patients (male: 108 (68.4%), median age: 65.3) were included. The SMI cutoff to define low SMI was ≤33 cm2/m2 for males and ≤28 cm2/m2 for females; 30 patients (19.0%) had low SMI. Patients with low SMI had a higher incidence of hematological toxicities (63.3% vs 32.0%, P = .001) and non-hematological toxicities (66.7% vs 36.7%, P = .003). Multivariable analysis indicated that low SMI and low serum albumin (≤28 g/L) were independent predictive factors of hematological toxicity, while low SMI and neutrophil-lymphocyte ratio ≥5 were predictive factors of non-hematological toxicity. Moreover, patients with low SMI had a significantly shorter OS (P = .011), lower response rate to chemotherapy (P = .045), and lower utilization of subsequent lines of treatment (P < .001).

Conclusions

Using pre-chemotherapy SMI cutoff (≤33 cm2/m2 for males and 28 cm2/m2 for females) one can identify individuals with a higher risk of severe chemotherapy toxicities and worse prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaStomach NeoplasmsHumansMaleFemaleAgedMiddle AgedPrognosisRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsAged, 80 and overAdult

Stichwörter der Autor:innen

chemotherapy toxicitiesgastric cancerhematological toxicitysarcopeniaskeletal muscle mass

Autor:innen und Institutionen

  • Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
  • Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
  • Department of Radiology, Queen Elizabeth Hospital, Jordan, Hong Kong.

ORCID-Profile: Wing-Lok Chan

Zitieren

APA

Chan, W. L., Yun, H. B., Cheung, E. E., Liu, M., Hou, L. Y., Lam, K. O., Wong, I. Y., Chiu, W. K., Law, S., & Kwong, D. (2024). Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancer. The Oncologist, 29(10), e1272-e1279. https://doi.org/10.1093/oncolo/oyae123

Vancouver

Chan WL, Yun HB, Cheung EE, Liu M, Hou LY, Lam KO, et al. Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancer. The Oncologist. 2024;29(10):e1272-e1279. doi:10.1093/oncolo/oyae123

BibTeX
@article{Chan2024,
  author = {Chan, Wing-Lok and Yun, Ho-Kwan Bryan and Cheung, Emina Edith and Liu, Michelle and Hou, Li-Yu and Lam, Ka-On and Wong, Ian Yu-Hong and Chiu, Wan-Hang Keith and Law, Simon and Kwong, Dora},
  title = {Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancer},
  journal = {The Oncologist},
  year = {2024},
  volume = {29},
  number = {10},
  pages = {e1272--e1279},
  doi = {10.1093/oncolo/oyae123}
}
Kostenlos starten →